| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Prediction of overall survival for patients with metastatic castration-resistant prostate cancer: development of a prognostic model through a crowdsourced challenge with open clinical trial data. | Lancet Oncol | 2016 | 0.98 |
| 2 | Novel therapeutic strategies for metastatic prostate cancer in the post-docetaxel setting. | Oncologist | 2011 | 0.90 |